These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21113188)

  • 1. Large pericardial effusion as a complication in adults undergoing SCT.
    Norkin M; Ratanatharathorn V; Ayash L; Abidi MH; Al-Kadhimi Z; Lum LG; Uberti JP
    Bone Marrow Transplant; 2011 Oct; 46(10):1353-6. PubMed ID: 21113188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients.
    Liu YC; Gau JP; Hong YC; Yu YB; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    Ann Hematol; 2012 Dec; 91(12):1953-8. PubMed ID: 22869091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
    Matin A; Smith BH; Mangaonkar A; Duffy DJ; Wolf R; Alkhateeb H; Shah MV; Hogan WJ; Litzow MR
    Transplant Cell Ther; 2023 May; 29(5):324.e1-324.e6. PubMed ID: 36682472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Tzeng CH
    Br J Haematol; 2015 Jun; 169(5):737-45. PubMed ID: 25818840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease.
    Neier M; Jin Z; Kleinman C; Baldinger L; Bhatia M; Silver E; van de Ven C; Morris E; Satwani P; George D; Garvin J; Bradley MB; Schwartz J; Cairo MS
    Bone Marrow Transplant; 2011 Apr; 46(4):529-38. PubMed ID: 20581882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients.
    Rhodes M; Lautz T; Kavanaugh-Mchugh A; Manes B; Calder C; Koyama T; Liske M; Parra D; Frangoul H
    Bone Marrow Transplant; 2005 Jul; 36(2):139-44. PubMed ID: 15908968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericardial Effusion Following Hematopoietic Cell Transplantation in Children and Young Adults Is Associated with Increased Risk of Mortality.
    Cox K; Punn R; Weiskopf E; Pinsky BA; Kharbanda S
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1165-1169. PubMed ID: 28390986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
    Nagler A; Or R; Naparstek E; Varadi G; Slavin S
    Exp Hematol; 2000 Sep; 28(9):1096-104. PubMed ID: 11008023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes.
    Tinianow A; Gay JC; Bearl DW; Connelly JA; Godown J; Kitko CL
    Pediatr Transplant; 2020 Aug; 24(5):e13748. PubMed ID: 32485042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
    Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience.
    Diamond M; Ruiz-Mesa C; Corrales-Medina FF; Tamariz LJ; Ziga E; Swaminathan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):132-136. PubMed ID: 28945662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.
    Abdelbary H; Magdy R; Moussa M; Abdelmoaty I
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):11. PubMed ID: 32372257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies.
    Branson K; Chopra R; Kottaridis PD; McQuaker G; Parker A; Schey S; Chakraverty RK; Craddock C; Milligan DW; Pettengell R; Marsh JC; Linch DC; Goldstone AH; Williams CD; Mackinnon S
    J Clin Oncol; 2002 Oct; 20(19):4022-31. PubMed ID: 12351600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
    El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
    Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT.
    Frangoul H; Min E; Wang W; Chandrasekhar R; Calder C; Evans M; Manes B; Bruce K; Brown V; Ho R; Domm J
    Bone Marrow Transplant; 2013 Nov; 48(11):1456-9. PubMed ID: 23708706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericardial effusion after pediatric hematopoietic cell transplant.
    Aldoss O; Gruenstein DH; Bass JL; Steinberger J; Zhang Y; Defor TE; Tolar J; Verneris MR; Orchard PJ
    Pediatr Transplant; 2013 May; 17(3):294-9. PubMed ID: 23464863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.